("QHT"), established in 2000, is a hi-tech enterprise specializing in prebiotic products research and development, production and sales. QHT controls independent research and development core technologies and patented technologies. QHT is the major proponent for Chinese approval of FOS as a nutritional fortifier and the major drafter of the FOS and GOS national standards. In 2010 QHT was listed on
the Shenzhen Stock Exchange in China and quickly developed into a leading brand and benchmarking enterprise in the microbiome health industry. In 2013 QHT was rated as one of Asia's 200 Best Small and Mid-Sized Companies by Forbes magazine, which has further enhanced the company's reputation and brand value. Its core products -- Fructooligosaccharides ("FOS") and Galactooligosaccharides ("GOS") -- are widely recognized as essential probiotics that have significant beneficial effects of a properly balancd human digestive microbiome.
